Business Wire

UMA Launches from Europe to Shape the Global Future of Physical AI

1.12.2025 23:52:00 CET | Business Wire | Press release

Share

UMA (Universal Mechanical Assistant), a new robotics intelligence company founded by former leaders from Tesla, Google DeepMind, Nvidia and Hugging Face, launches today with a clear goal: to bring advanced AI into the physical world and build humanoid robots ready for real work, in real environments, at scale.

UMA’s founders were instrumental in shaping the last decade of breakthroughs in deep learning, robotics and open-source AI. They are convinced that the next era of artificial intelligence won’t unfold on screens, it will happen in warehouses, hospitals, labs, factories and homes, where machines must face friction, unpredictability and human complexity. UMA is built for this transition: from digital intelligence to physical autonomy.

AI Is Moving Off the Screen and into the World

The past ten years gave rise to generative models, multimodal systems and language-based intelligence. The next decade will be defined by robotics, powered by an AI that can see, move, manipulate and make decisions in dynamic environments. Analysts project the humanoid and mobile robotics market to reach $243 billion by 2035, climbing to more than $5 trillion by 2050, fueled by structural labor shortages, rising operational costs and the need for resilient, always-on production.

UMA’s founders firmly believe this shift requires a new kind of robotic intelligence: one that is data-driven, adaptable, self-improving and safe enough to operate shoulder-to-shoulder with human teams.

Built by Engineers and Researchers Who Helped Define Modern AI

UMA’s founding team represents decades of breakthroughs across the US, Europe and Asia: Remi Cadene pioneered Tesla Autopilot and Optimus, and democratized robot learning with LeRobot at Hugging Face, Pierre Sermanet advanced deep learning and robotics research for two decades at New York University and Google DeepMind, Simon Alibert co-founded LeRobot and brings expertise in scalable learning infrastructure, Robert Knight designed humanoid robots for 25+ years and open-sourced the widely used SO-100 robot.

Together, they bring deep technical expertise and a shared belief: the world needs robots that aren’t just impressive in demos, but reliable in production.

Solving the Hardest Global Operational Challenges

Industrial and societal pressures are making advanced robotics not just desirable, but inevitable.

Across logistics, healthcare and aging societies, the constraints are structural:

  • In warehousing and logistics, labor is often the single biggest cost driver, representing up to 50% of total warehouse operating expenses, and annual warehouse worker turnover in the US frequently exceeds 40%, far above the national average (Business Plan Templates).
  • Globally, healthcare systems are heading toward a shortage of around 10 million health workers by 2030, including an estimated 4.8 million nurses and midwives, despite being the backbone of care delivery.
  • The world is aging fast: people aged 65 and over already account for about 10% of the global population and are projected to reach 16% by 2050, or roughly 1.6 billion people, reshaping demand for care, assistance and autonomy.

These are not abstract statistics. They determine whether hospitals stay staffed, whether supply chains keep moving, and whether older adults can live safely and independently.

UMA wants robotics to be a lever for resilience: machines that handle physical strain, repetitive tasks and environmental unpredictability, so people can focus on higher-value, human work.

Two Systems Designed for Complementary Real-World Use

UMA is developing two complementary systems.

  1. A mobile industrial robot with dual arms designed for environments such as warehouses and assembly lines, where precision and repeatability are essential.
  2. A compact humanoid robot designed to navigate human-centric spaces and collaborate directly with workers.

Together, these systems offer a pragmatic path toward high-reliability robotics deployment, balancing innovation with the real operational need of industry.

A Human-Centered Vision to Robotics

UMA’s approach is intentionally grounded in durability, safety and real-world performance. The company builds systems that are lightweight, repairable, with a commitment to full civilian use. UMA believes robotics should enhance human capability; bringing more safety to people, time and new possibilities.

Built for Global Scale, Backed by Global Leaders

UMA is now hiring engineers, researchers and operational specialists from around the world who want to push the boundaries of physical intelligence. The company values high standards and firmly believes world-class innovation thrives on diverse perspectives and backgrounds.

UMA is supported by global investors such as Greycroft, Relentless, Unity Growth, >Commit, Factorial, ALM Ventures and Drysdale, along with leading figures in AI including Olivier Pomel, Yann LeCun, Thomas Wolf, Soumith Chintala and Nicolas Rosberg.

Sources (selection)

Gartner, Hype Cycle for Advanced Mobile Robots 2024 ; Gartner Press Releases 2024-2025 ; Data Bridge Market Research (Warehouse Robotics, Service Robotics, Cloud Robotics) ; United Nations World Urbanization Prospects ; European Commission Eurostat 2025 ; European Data Journalism Network ; EFN – European Federation of Nurses ; Le Monde ; Euronews ; MWPVL International ; Capstone Logistics ; INSEE 2022 ; DREES ; Ministry of Ecology ; Oxfam France ; ONU ; ADEME ; Sami Éco.

About UMA

Founded in Paris in 2025, UMA develops mobile and humanoid robots powered by advanced physical intelligence and designed for real-world performance. Its team brings experience from Tesla, Google DeepMind, Nvidia and Hugging Face. Backed by a significant first round, UMA is accelerating development and preparing pilot programs in logistics, manufacturing and healthcare in 2026. UMA’s vision is to deliver intelligent robots that make work safer, that improve productivity, and make daily life better for millions.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251201209844/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release

Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into

U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release

Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted

Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release

Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,

Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release

Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye